Advertisement

Ads Placeholder
Loading...

Starpharma Holdings Limited

SPHRF•PNK
Healthcare
Biotechnology
$0.35
$0.010(2.94%)
U.S. Market opens in 5h 4m

Starpharma Holdings Limited (SPHRF) Stock Overview

Explore Starpharma Holdings Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap147.3M
P/E Ratio-64.07
EPS (TTM)$-0.01
ROE-0.16%
Fundamental Analysis

AI Price Forecasts

1 Month$0.29
3 Months$0.33
1 Year Target$0.38

SPHRF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Starpharma Holdings Limited (SPHRF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 65.85, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.38.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -64.07 and a market capitalization of 147.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.94%
5-Day Change
2.94%
1-Month Change
9.38%
3-Month Change
20.69%
6-Month Change
52.17%
Year-to-Date (YTD) Change
20.69%
1-Year Change
400.00%
3-Year Change
16.67%
5-Year Change
-78.40%
All-Time (Max) Change
N/A

Contact Information

https://starpharma.com
61 3 8532 2700
4-6 Southampton Crescent, Abbotsford, VIC, 3067

Company Facts

400 Employees
IPO DateApr 30, 2007
CountryAU
Actively Trading

Frequently Asked Questions